Clinical Trial Update: Trabectedin in Treating Patients With Metastatic Pancreatic Cancer After First-Line Chemotherapy [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating trabectedin for metastatic pancreatic cancer after first-line chemotherapy has completed. The update indicates the study has finished…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Trabectedin (trabectedin)

Snippet

Sponsor: IRCCS San Raffaele | Conditions: Pancreatic Cancer | Phase 2 | Status: COMPLETED